← Product Code [DQK](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQK) · K110132 # MUSE CARDIOLOGY INFORMATION SYSTEM (K110132) _Ge Medical Systems Information Technologies, Inc. · DQK · May 25, 2011 · Cardiovascular · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQK/K110132 ## Device Facts - **Applicant:** Ge Medical Systems Information Technologies, Inc. - **Product Code:** [DQK](/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQK.md) - **Decision Date:** May 25, 2011 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 870.1425 - **Device Class:** Class 2 - **Review Panel:** Cardiovascular - **Attributes:** Software as a Medical Device, Pediatric ## Indications for Use The MUSE Cardiology Information System is intended to store, access and manage cardiovascular information on adult and pediatric patients. The information consists of measurements, text, and digitized waveforms. The MUSE Cardiology Information System provides the ability to review and edit electrocardiographic procedures on screen, through the use of reviewing, measuring, and editing tools including ECG serial comparison and interpretive 12-lead analysis. The MUSE Cardiology Information System is intended to be used under the direct supervision of a licensed healthcare practitioner, by trained operators in a hospital or facility providing patient care. The MUSE Cardiology Information System is not intended for real time monitoring. The MUSE Cardiology Information System is not intended for pediatric serial comparison. ## Device Story MUSE Cardiology Information System is a network PC-based client/server system for centralized storage and management of cardiovascular data (Resting ECG, Stress, Holter, HiRes) from GE and non-GE diagnostic equipment. Operators (trained staff) use the system to review, measure, and edit digitized waveforms and reports on-screen. Key features include interpretive 12-lead analysis and ECG serial comparison for adults. The system generates management, ad-hoc database, and clinical patient reports. It is used in hospital or clinical settings to support healthcare practitioners in clinical decision-making by providing organized access to diagnostic cardiology information. It is not for real-time monitoring. ## Clinical Evidence No clinical data. Substantial equivalence supported by bench testing, including risk analysis, requirements/design reviews, code inspection, module verification, system integration testing, performance verification, safety testing, and simulated use validation. ## Technological Characteristics Network PC-based client/server architecture. Manages diagnostic cardiology data (ECG, Stress, Holter, HiRes). Features include interpretive 12-lead analysis and serial comparison tools. Complies with voluntary standards for safety and performance. ## Regulatory Identification A programmable diagnostic computer is a device that can be programmed to compute various physiologic or blood flow parameters based on the output from one or more electrodes, transducers, or measuring devices; this device includes any associated commercially supplied programs. ## Predicate Devices - MUSE Cardiology Information System ([K072502](/device/K072502.md)) - MUSE Cardiology Information System w/ VMWare ([K083639](/device/K083639.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0}------------------------------------------------ K110132 pg 1 of 2 MAY 2 5 2011 Image /page/0/Picture/2 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'G' and 'E' intertwined within a circle. The letters are stylized and appear to be in a sans-serif font. ## GE Healthcare 510(k) Premarket Notification Submission ### 510(k) Summary In accordance with 21 CFR 807.92 the following summary of information is provided: January 12, 2011 Date: | Submitter: | GE Medical Systems Information Technologies
9900 Innovation Drive
Wauwatosa, WI 53226 | |------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Primary Contact Person: | Kristin Pabst
Regulatory Affairs Manager
GE Medical Systems Information Technologies
Phone: (414) 721-3104
Fax: (414) 721-3863 | | Secondary Contact
Person: | Patricia Taige
Regulatory Affairs Leader
GE Medical Systems Information Technologies
Phone (414) 721-3222
FAX: (414) 721-3863 | | Device: Trade Name: | MUSE Cardiology Information System | | Common/Usual Name: | ECG Analysis Computer | | Classification Names: | Programmable Diagnostic Computer (21 CFR 870.1425) | | Product Code: | DQK | | Predicate Device(s): | MUSE Cardiology Information System K#072502
MUSE Cardiology Information System w/ VMWare K#083639 | | Device Description: | The MUSE Cardiology Information System is a network PC-
based system comprised of a client workstation/server
configuration that manages adult and pediatric diagnostic
cardiology data by providing centralized storage and ready
access to a wide range of data/reports (e.g. Resting ECG,
Stress, Holter, HiRes) from GE and non-GE diagnostic and
monitoring equipment. The device provides the ability to:
• Review and edit stored data consisting of measurements, text,
and digitized waveforms on screen, through the use of reviewing,
measuring, and editing tools including ECG serial comparison
and interpretive 12-lead analysis.
• Generate formatted management reports, ad-hoc database
search reports and clinical patient reports on selected stored
data. | {1}------------------------------------------------ Image /page/1/Picture/0 description: The image shows the General Electric (GE) logo. The logo consists of the letters 'G' and 'E' intertwined within a circular border. The letters are stylized and appear to be in a cursive font. The logo is black and white. ## GE Healthcare ### 510(k) Premarket Notification Submission The MUSE Cardiology Information System is intended to store, Intended Use: access and manage cardiovascular information on adult and pediatric patients. The information consists of measurements, text, and digitized waveforms. The MUSE Cardiology Information System ' provides the ability to review and edit electrocardiographic procedures on screen, through the use of reviewing, measuring, and editing tools including ECG serial comparison and interpretive 12-lead analysis. The MUSE Cardiology_Information_System_is_intended_to_be_used_under_the direct supervision of a licensed healthcare practitioner, by trained operators in a hospital or facility providing patient care. The MUSE Cardiology Information System is not intended for real time monitoring. The MUSE Cardiology Information System is not intended for pediatric serial comparison. The proposed MUSE Cardiology Information System employs Technology: the same functional scientific technology as the predicate devices MUSE Cardiovascular Information System (K072502) and MUSE Cardiovascular Information System w/ VMWare (K083639). #### Determination of Summary of Non-Clinical Tests: Substantial Equivalence: The MUSE Cardiology Information System complies with voluntary standards as detailed in Section 9 and 17 of this premarket submission. The following quality assurance measures are applied to the development of the system: - Risk Analysis . - Requirements Reviews . - . Design Reviews - . Code Inspection - Testing on unit level (Module verification) . - . Integration testing (System verification) - Performance testing (Verification) . - Safety testing (Verification) - Simulated use testing (Validation) ### Summary of Clinical Tests: The subject of this premarket submission, MUSE Cardiology Information System, did not require clinical studies to support substantial equivalence. Conclusion: GE Healthcare considers the MUSE Cardiology Information System to be as safe, as effective, and performance is substantially equivalent to the predicate devices. {2}------------------------------------------------ ### DEPARTMENT OF HEALTH & HUMAN SERVICES Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the perimeter. Inside the circle is an abstract symbol that resembles a stylized eagle or bird in flight, composed of three curved lines. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room ~WO66-G609 Silver Spring, MD 20993-0002 GE Medical Systems Information Technologies, Inc c/o Ms. Kristin Pabst Regulatory Affairs Manager 9900 West Innovation Drive Wauwatosa, WI 53226 MAY 2 5 2011 Re: K110132 > Trade/Device Name: Muse Cardiology Information System Regulation Number: 21 CFR 870.1425 Regulation Name: Programmable Diagnostic Computer Regulatory Class: Class II (two) Product Code: DQK Dated: May 4, 2011 Received: May 6, 2011 Dear Ms. Pabst: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. {3}------------------------------------------------ Page 2 - Ms. Kristin Pabst Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHQffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, for Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ K110132 pg lofl Image /page/4/Picture/1 description: The image shows the General Electric (GE) logo. The logo consists of the letters "GE" intertwined and enclosed within a circular border. The letters and the border are in black, contrasting with the white background. # GE Healthcare 510(k) Premarket Notification Submission 510(k) Number (if known): MUSE Cardiology Information System Device Name: Indications for Use: The MUSE Cardiology Information System is intended to store, access and manage cardiovascular information on adult and pediatric patients. The information consists of measurements, text, and digitized waveforms. The MUSE. Cardiology Information System provides the ability to review and edit electrocardiographic procedures on screen, through the use of reviewing, and editing tools including ECG serial comparison and interpretive 12-lead analysis. The MUSE Cardiology Information System is intended to be used under the direct supervision of a licensed healthcare practitioner, by trained operators in a hospital or facility providing patient care. The MUSE Cardiology Information System is not intended for real-time patient monitoring. The MUSE Cardiology Information System is not intended for pediatric serial comparison. Prescription Use_X AND/OR (Part 21 CFR 801 Subpart D) Over-The-Counter Use (Part 21 CFR 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) Division of Cardiovascular-Device 510(k) Number K110132 --- **Source:** [https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQK/K110132](https://fda.innolitics.com/submissions/CV/subpart-b%E2%80%94cardiovascular-diagnostic-devices/DQK/K110132) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com